CClinicalTrials.gg
CompletedNCT06790459Updated Jan 24, 2025

Effects of the Ultra-low Frequencies TENS on the Arousal Circuits

An interventional study of UlfTens (Ultra-low-frequencies Transcutaneous electrical nervous stimulation) in Pupil Diameter and Arousal, sponsored by University of L'Aquila. Completed at 1 site in Italy. Open to female participants aged 20 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-24.

Sponsored by University of L'Aquila · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Sep 2024, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 30 Years
Sex
Female
01

Study summary

Pupil size is associated with the activity of the noradrenergic system, with an increase reflecting a higher state of arousal. Transmucosal electrical stimulation of the tongue could treat disorders related to dysfunctions of this system, and trigeminal stimulation through ULFTENS (TUD) has shown some positive effects. However, no studies have examined the effect of stimulation of the anterior mucosa of the tongue on pupil size as an indicator of arousal. The aim of this study will be to evaluate the effect of ULFTENS stimulation on pupil size in the dark.

Read the detailed description

Changes in pupil size are indicative of the activity of the noradrenergic system, with pupil dilation associated with a higher state of arousal. According to various studies, odontological ULFTENS, through trigeminal stimulation, can help rebalance this altered system with positive effects. Our goal is to harness the capabilities of ULFTENS by stimulating the dorsal lingual mucosa and evaluating its effects on pupil size in the dark. Healthy women aged between 20 and 30 will be recruited and divided into two groups: a control group and an experimental group. Participants in the control group will lie down on a bed with their eyes closed, and will then be asked to open their eyes without moving their eyelids. Pupil diameter will be measured using a pupillometer for 15 seconds. This procedure will be repeated twice. The experimental group will receive a tongue stimulator connected to the ULFTENS, which will be activated after the first measurement. The stimulation will last approximately 15 minutes, with a second measurement taken after 15 seconds. At the end of the stimulation, the final measurement will be taken. The goal is to measure the pupil diameter of both eyes at the three time points and compare the results between the two groups to assess the effect of the stimulator on arousal circuits.

02

Conditions studied

  • Pupil Diameter
  • Arousal

Keywords

  • Pupil size
  • ULFTENS
  • Trigeminal electrical stimulation
  • tongue stimulation
03

In context

Lead sponsor

University of L'Aquila is the lead sponsor of 45 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • good health status and physical fitness
  • female sex
  • age between 20 and 30 years
  • non-smoker
  • no more than 3 espresso coffees per day
  • no intake of stimulant or psychotropic drugs in general
  • body mass index between 18.5 and 24.9

Exclusion criteria

Exclusion Criteria:

  • presence of acute and/or chronic cardiocirculatory and respiratory disorders
  • metabolic and autonomic system disorders
  • intake of peripheral and central nervous system excitatory or inhibiting substances
  • presence of generalized anxiety and/or panic attacks, or mood disorders.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Experimental group

    20 women of 20-30 years would be enrolled to the experimental group. They will undergone to tongue stimulation with ULFTENS device for 15 minutes. Pupils' diameter will be measure for three time points, before, during and after the tongue stimulation

    Device: UlfTens (Ultra-low-frequencies Transcutaneous electrical nervous stimulation)

  • No intervention
    Control group

    20 women of 20-30 years will be enrolled to the control group. Their pupils' diameter will be measure at three time points

Interventions

  • DeviceUlfTens (Ultra-low-frequencies Transcutaneous electrical nervous stimulation)

    ULFTENS device will be administered in the experimental group for 15 minutes

06

What researchers measure

Primary outcomes

  1. Pupil size

    left and right pupils diameter will be measured using a pupillometry. Images of the pupils will be acquired by the Oculus system, using two infrared CCD cameras (resolution 720 × 576 pixels, 256 grey levels) mounted on a light helmet (1.5 kg), with sampling frequency of 25 frame/s. The eyes will be illuminated with an infrared diode with 880 nm of wave length.

    Time frame: 12 minutes

07

Study locations

1 site
  • Dental Clinic, Mesva department
    L'Aquila, Italia 67100, Italy
08

References and documents

Publications

  • Monaco A, Cattaneo R, Smurra P, Di Nicolantonio S, Cipriano F, Pietropaoli D, Ortu E. Trigeminal electrical stimulation with ULFTENS of the dorsal anterior mucosal surface of the tongue: Effects on Heart Rate Variability (HRV). PLoS One. 2023 May 10;18(5):e0285464. doi: 10.1371/journal.pone.0285464. eCollection 2023. PubMed 37163499 ↗
  • Monaco A, Cattaneo R, Di Nicolantonio S, Strada M, Pietropaoli D, Ortu E. Effects of trigeminal neurostimulation on heart rate variability: comparing cutaneous (Tragus) and tongue (Antero-Dorsal mucosa) stimulation. BMC Oral Health. 2024 Oct 20;24(1):1257. doi: 10.1186/s12903-024-04914-2. PubMed 39428464 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06790459
Lead sponsor
University of L'Aquila
Responsible party
Sara Di Nicolantonio (PhD candidate, University of L'Aquila) — Principal investigator
First posted
Jan 24, 2025
Start date
Sep 24, 2024
Primary completion
Oct 2, 2024
Completion
Oct 30, 2024
Last update
Jan 24, 2025

Study contacts

Annalisa Monaco
principal investigator · University of L'Aquila

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion